KRAS and cancer: Increasing evidence has shown that the Kras/ERK pathway–mediated metabolism reprogramming is a requirement for uncontrolled cell proliferation and maintenance of malignant property, as cancer cells require both sufficient ATP supply and biosynthetic precursors as cellular building blocks (43).